News FocusCorporate Research

Japan's Drugmakers Need a Boost to Compete

See allHide authors and affiliations

Science  17 May 2002:
Vol. 296, Issue 5571, pp. 1231
DOI: 10.1126/science.296.5571.1231

You are currently viewing the summary.

View Full Text

Summary

TOKYO-- Japan's Ministry of Health, Labor, and Welfare estimates that on average domestic pharmaceutical firms spend only one-fifth as much on research, in absolute terms, as do their U.S. counterparts. And the gap seems to be growing.